Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. More Details
High growth potential with excellent balance sheet.
Share Price & News
How has Teladoc Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TDOC has not had significant price volatility in the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: TDOC exceeded the US Healthcare Services industry which returned 64.5% over the past year.
Return vs Market: TDOC exceeded the US Market which returned 13.8% over the past year.
Price Volatility Vs. Market
How volatile is Teladoc Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StIntroducing Teladoc Health (NYSE:TDOC), The Stock That Soared 764% In The Last Five Years
1 month ago | Simply Wall StTeladoc Health, Inc.'s (NYSE:TDOC) Path To Profitability
2 months ago | Simply Wall StWhat Can We Conclude About Teladoc Health's (NYSE:TDOC) CEO Pay?
Is Teladoc Health undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: TDOC ($219) is trading above our estimate of fair value ($151.4)
Significantly Below Fair Value: TDOC is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: TDOC is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.
PE vs Market: TDOC is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TDOC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TDOC is overvalued based on its PB Ratio (13.4x) compared to the US Healthcare Services industry average (5.2x).
How is Teladoc Health forecast to perform in the next 1 to 3 years based on estimates from 25 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TDOC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: TDOC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TDOC's is expected to become profitable in the next 3 years.
Revenue vs Market: TDOC's revenue (25.3% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: TDOC's revenue (25.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TDOC's Return on Equity is forecast to be low in 3 years time (1.7%).
How has Teladoc Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TDOC is currently unprofitable.
Growing Profit Margin: TDOC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TDOC is unprofitable, and losses have increased over the past 5 years at a rate of 14.4% per year.
Accelerating Growth: Unable to compare TDOC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TDOC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).
Return on Equity
High ROE: TDOC has a negative Return on Equity (-7.31%), as it is currently unprofitable.
How is Teladoc Health's financial position?
Financial Position Analysis
Short Term Liabilities: TDOC's short term assets ($1.4B) exceed its short term liabilities ($123.5M).
Long Term Liabilities: TDOC's short term assets ($1.4B) exceed its long term liabilities ($1.0B).
Debt to Equity History and Analysis
Debt Level: TDOC's debt to equity ratio (73.2%) is considered high.
Reducing Debt: TDOC's debt to equity ratio has reduced from 76.8% to 73.2% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable TDOC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: TDOC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 35% per year.
What is Teladoc Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TDOC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TDOC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TDOC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TDOC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TDOC's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jason Gorevic (48 yo)
Mr. Jason N. Gorevic has been Chief Executive Officer at Teladoc Health, Inc. (formerly known as Teladoc, Inc.) (Formerly TelaDoc Medical Services Inc.) since June 2009. Mr. Gorevic serves as Director of D ...
CEO Compensation Analysis
Compensation vs Market: Jason's total compensation ($USD8.00M) is about average for companies of similar size in the US market ($USD11.36M).
Compensation vs Earnings: Jason's compensation has increased whilst the company is unprofitable.
|CEO & Director||11.25yrs||US$8.00m||0.82% |
|Chief Financial Officer||1.25yrs||US$3.65m||0.011% |
|Chief Operating Officer||1.17yrs||US$3.93m||0.0034% |
|Chief Legal Officer & Secretary||5.58yrs||US$1.94m||0.00025% |
|Chief Marketing Officer||4.67yrs||US$2.00m||0.016% |
|Senior Vice President of Finance||0.25yr||US$725.49k||0.0012% |
|Co-Founder||18.67yrs||no data||no data|
|Senior VP||0.25yr||no data||no data|
|Chief Information Officer||no data||no data||no data|
|Vice President of Investor Relations||no data||no data||no data|
|Director of Communication||no data||no data||no data|
|Senior Vice President of Business Development||5.67yrs||no data||0.0049% |
Experienced Management: TDOC's management team is considered experienced (4.7 years average tenure).
|CEO & Director||11.25yrs||US$8.00m||0.82% |
|Independent Director||10.83yrs||US$230.00k||0.0060% |
|Independent Director||4yrs||US$242.50k||0.0048% |
|Independent Director||5.58yrs||US$239.17k||0% |
|Independent Chairman||5.75yrs||US$265.83k||0.12% |
|Independent Director||6yrs||US$229.58k||0.0067% |
|Independent Director||3.58yrs||US$224.58k||no data|
|Independent Director||4.25yrs||US$220.00k||0.0011% |
|Independent Director||1.92yrs||US$219.17k||0.0037% |
|Independent Director||0.58yr||no data||no data|
Experienced Board: TDOC's board of directors are considered experienced (4.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.8%.
Teladoc Health, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Teladoc Health, Inc.
- Ticker: TDOC
- Exchange: NYSE
- Founded: 2002
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$17.789b
- Shares outstanding: 81.23m
- Website: https://www.teladochealth.com
Number of Employees
- Teladoc Health, Inc.
- 2 Manhattanville Road
- Suite 203
- New York
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|TDOC||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Jul 2015|
|4LL||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Jul 2015|
|0LDR||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Jul 2015|
|TDOC *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Jul 2015|
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic c ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/27 06:15|
|End of Day Share Price||2020/09/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.